Followers | 437 |
Posts | 42954 |
Boards Moderated | 2 |
Alias Born | 05/08/2006 |
Tuesday, August 25, 2015 11:12:22 AM
GrowBLOX Sciences (OTC: GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today announced John Poss as its new chief financial officer.
“First joining us as a consultant, the performance of John Poss and his impact on our company, made the hiring of him as a full-time key executive an obvious choice. This choice supports our transition from the engineering intensive development stage to the day-to-day operations of producing an excellent product, branding it appropriately, and maximizing our revenue. We feel that John will be instrumental in helping us to achieve that transition smoothly and expeditiously,” stated GrowBLOX Sciences CEO Craig Ellins. “John’s experience, in business and in life, speaks for itself.”
The company describes Poss as having “an aptitude for solving complex problems and improving performance in technology, logistics, business systems, and finance.” Poss previously served as CFO, CEO, COO, and CTO of both public and private companies with sales ranging from $10 million to $450 million as well as over 15 years of consulting experience. He also has extensive M&A experience, both buy and sell side, including private equity. His success has been demonstrated across multiple industries, including telecommunications, transportation/logistics, manufacturing, finance/mortgage, construction, mining, oil, gas, and public accounting/consulting. Additionally, he is a proven innovator with two issued patents. Further, he’s led major projects and negotiated over $1 billion in commercial agreements and dispute resolutions in 15 countries.
“I am very happy to join GrowBLOX. As a cancer survivor, I am a strong believer in the value of medical marijuana in many cases and to treat many diseases. I am excited to be a part of this revolution, which has been developing, slowly, throughout my lifetime,” stated Poss.
For more information visit http://growblox.com.
Recent GBLX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:15:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:31:48 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2023 08:18:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 08:12:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/30/2023 12:00:24 PM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM